US pharma giant Viatris to divest India API, women's healthcare businesses for USD 1.2 billion Ruchika Sharma3 Oct 2023 5:30 PM ISTBoth the India deals are expected to close in Q1 2024, according to the Viatris statement.
Indian Pharma cos get green signal to distribute generic Bedaquiline in low, middle income countries Ruchika Sharma3 Oct 2023 3:30 PM ISTNew Delhi: Indian pharmaceutical manufacturers have received a green light to distribute the generic anti-TB drug Bedaquiline to other countries...
Preventive therapy for RSV: AstraZeneca India gets CDSCO nod for Palivizumab injection Ruchika Sharma3 Oct 2023 2:30 PM ISTNew Delhi: AstraZeneca Pharma India Ltd., a science-led biopharmaceutical company, has announced the marketing approval from Central Drugs Standard...
Union Home Minister Amit Shah inaugrates permanent campus of NIPER Ahmedabad Ruchika Sharma3 Oct 2023 1:30 PM ISTNIPER should aim to become the world's topmost institute not only in education but also in the field of research, unless India achieves mastery in the...
Serum Institute-Oxford University malaria vaccine bags WHO recommendation Ruchika Sharma3 Oct 2023 12:30 PM ISTThe R21/Matrix-M malaria vaccine is an easily deployable vaccine that can be manufactured at mass scale and modest cost, enabling as many as hundreds...
Novo Nordisk gets USFDA nod for Rivfloza injection for rare genetic condition Ruchika Sharma3 Oct 2023 11:49 AM ISTRivfloza, the RNAi therapeutic by Novo Nordisk, was developed using the proprietary GalXC RNAi technology platform.
Lyka Labs Gets CDSCO Panel Nod To Manufacture, Market Atopic Dermatitis Drug Dr. Divya Colin2 Oct 2023 5:30 PM ISTNew Delhi: Lyka Lab has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO)...
USFDA to conduct more surprise checks of pharma factories in India Ruchika Sharma2 Oct 2023 3:00 PM ISTCaliff said that he expected India to continue being a dominant supplier to the US, the world's largest market for medicines.
AbbVie blood cancer combo therapy fails in late-stage study Ruchika Sharma2 Oct 2023 1:00 PM ISTUnited States: AbbVie has said a late-stage study of its experimental combination therapy to treat a form of blood cancer failed to meaningfully...
Viatris, Ocuphire Pharma get USFDA nod for Ryzumvi for treatment of Pharmacologically-Induced Mydriasis Ruchika Sharma2 Oct 2023 11:30 AM ISTPittsburgh: Viatris Inc., a global healthcare company, and Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company focused on...
Phase 3 Mariposa study evaluating Rybrevant plus Lazertinib meets primary endpoint in PFS in Non-Small Cell Lung Cancer: Janssen Ruchika Sharma2 Oct 2023 10:00 AM ISTRartan: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced positive topline results from the Phase 3 MARIPOSA study...
Eli Lilly settles whistleblower lawsuit over manufacturing problems Ruchika Sharma1 Oct 2023 4:30 PM ISTUnited States: Eli Lilly and Co and a former employee agreed to settle a lawsuit in which the worker claimed she was terminated after pointing out...
